CXCR4 and fatty liver disease: Previous studies showed that butyrate treatment relieves HF diet-induced hepatic steatosis in mice by upregulating miR-150 expression, downregulating C-X-C chemokine receptor type 4, enhancing insulin-induced gene activity, and suppressing lipogenic genes [25,39].